TerrAscend (TSNDF) Current Deferred Revenue (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Current Deferred Revenue of $4.4 million for Q1 2026, down 17.56% year-over-year from $5.3 million in Q1 2025, and up 10.02% quarter-over-quarter from $4.0 million in Q4 2025.
TerrAscend (TSNDF) Current Deferred Revenue (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Current Deferred Revenue for 6 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 17.56% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (down 17.56% YoY), while the FY2025 annual figure was $4.0 million, up 11.69% from the prior year.
- Current Deferred Revenue improved to $4.4 million in Q1 2026 per TSNDF's latest filing, from $4.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $5.3 million in Q1 2025 and bottomed at $2.0 million in Q1 2022.
- Historically, Current Deferred Revenue has averaged $3.7 million across 5 years, with a median of $4.0 million in 2025.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 174.04% — and 2025, when it decreased 21.82%.
- TerrAscend's Current Deferred Revenue stood at $2.9 million in 2022, then jumped by 41.53% to $4.2 million in 2023, then dropped by 13.94% to $3.6 million in 2024, then grew by 11.69% to $4.0 million in 2025, then grew by 10.02% to $4.4 million in 2026.
- Business Quant data shows TSNDF's Current Deferred Revenue at $4.4 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.41 Mn |
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Sep 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.15 Mn |
| Sep 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 3.09 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 1.07 Mn |